Literature DB >> 17826059

Egg retrieval with cryopreservation does not delay breast cancer treatment.

Andrea Madrigrano1, Lynn Westphal, Irene Wapnir.   

Abstract

BACKGROUND: Infertility is a concern to young women diagnosed with breast cancer. Advances in fertility technology have made it possible to bank fertilized embryos.
METHODS: Twenty-three women, ages 27 to 40 years, underwent stimulation/oocyte retrieval before the start of adjuvant therapies. Time intervals between retrieval and therapeutic procedures were analyzed.
RESULTS: The average stimulation to egg retrieval was 11.5 days (range 9-20 d). The average time interval from first evaluation to oocyte retrieval was 33.3 days (range 10-65 d). Overall, the mean time from definitive surgery to initiation of chemotherapy was 46.8 days (n = 20). For 6 patients referred by surgeons, the mean time from fertility consult to retrieval was 48.8 days (range 16-118 d), and from definitive surgery to initiation of chemotherapy was 45 days (range 15-93 d).
CONCLUSIONS: Egg retrieval cryopreservation can be integrated with breast cancer work-up and surgical procedures. Early referrals to a fertility specialist by surgeons will help patients' safeguard future childbearing.

Entities:  

Mesh:

Year:  2007        PMID: 17826059     DOI: 10.1016/j.amjsurg.2007.06.008

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  13 in total

Review 1.  Maintaining fertility in young women with breast cancer.

Authors:  Melissa C Hulvat; Jacqueline S Jeruss
Journal:  Curr Treat Options Oncol       Date:  2009-12

2.  Fertility preservation in young cancer patients--too little, too late?

Authors:  Helen Louise Robbins; Arooba Zahoor; Kevin Jones
Journal:  Support Care Cancer       Date:  2015-08-18       Impact factor: 3.603

3.  Prospective study of depression and anxiety in female fertility preservation and infertility patients.

Authors:  Angela K Lawson; Susan C Klock; Mary Ellen Pavone; Jennifer Hirshfeld-Cytron; Kristin N Smith; Ralph R Kazer
Journal:  Fertil Steril       Date:  2014-08-22       Impact factor: 7.329

4.  Triggering final oocyte maturation with gonadotropin-releasing hormone agonist (GnRHa) versus human chorionic gonadotropin (hCG) in breast cancer patients undergoing fertility preservation: an extended experience.

Authors:  Jhansi Reddy; Volkan Turan; Giuliano Bedoschi; Fred Moy; Kutluk Oktay
Journal:  J Assist Reprod Genet       Date:  2014-05-23       Impact factor: 3.412

5.  Pretreatment fertility counseling and fertility preservation improve quality of life in reproductive age women with cancer.

Authors:  Joseph M Letourneau; Erin E Ebbel; Patricia P Katz; Audra Katz; Wei Z Ai; A Jo Chien; Michelle E Melisko; Marcelle I Cedars; Mitchell P Rosen
Journal:  Cancer       Date:  2011-09-01       Impact factor: 6.860

Review 6.  Psychological Counseling of Female Fertility Preservation Patients.

Authors:  Angela K Lawson; Susan C Klock; Mary Ellen Pavone; Jennifer Hirshfeld-Cytron; Kristin N Smith; Ralph R Kazer
Journal:  J Psychosoc Oncol       Date:  2015

Review 7.  Ovarian manipulation in ART: going beyond physiological standards to provide best clinical outcomes.

Authors:  Israel Ortega; Juan A García-Velasco; Antonio Pellicer
Journal:  J Assist Reprod Genet       Date:  2018-07-28       Impact factor: 3.412

8.  On-Site Fertility Preservation Services for Adolescents and Young Adults in a Comprehensive Cancer Center.

Authors:  Mary Peavey; Sara Arian; William Gibbons; Karen Lu; David Gershenson; Terri Woodard
Journal:  J Adolesc Young Adult Oncol       Date:  2016-11-15       Impact factor: 2.223

Review 9.  Reproductive health in the adolescent and young adult cancer patient: an innovative training program for oncology nurses.

Authors:  Susan T Vadaparampil; Nicole M Hutchins; Gwendolyn P Quinn
Journal:  J Cancer Educ       Date:  2013-03       Impact factor: 2.037

Review 10.  Current approach to fertility preservation by embryo cryopreservation.

Authors:  Giuliano Bedoschi; Kutluk Oktay
Journal:  Fertil Steril       Date:  2013-03-25       Impact factor: 7.329

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.